1-3 of 3
Paulina B. Lange
Close
Sort by
Journal Articles

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

John Koreth, MD, Haesook T. Kim, PhD, Paulina B Lange, Philippe Armand, MD PhD, Corey S. Cutler, MD MPH, Vincent T. Ho, MD, Brett Glotzbecker, MD, Rushdia Z. Yusuf, MBBS, MPH, Sarah Nikiforow, MD PhD, Bimalangshu R. Dey, MD PhD, Malgorzata McMasters, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Robert J. Soiffer, MD, Joseph H Antin, MD, Edwin P. Alyea, MD
Journal: Blood
Blood (2016) 128 (22): 508.
https://doi.org/10.1182/blood.V128.22.508.508
Published: 2016
Journal Articles

Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease

Clinical Trials & Observations
John Koreth, Haesook T. Kim, Kyle T. Jones, Paulina B. Lange, Carol G. Reynolds, Marie J. Chammas, Katherine Dusenbury, Jennifer Whangbo, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Yi-Bin Chen, David Avigan, Bruce R. Blazar, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer
Journal: Blood
Blood (2016) 128 (1): 130–137.
https://doi.org/10.1182/blood-2016-02-702852
Published: 2016
Includes: Supplemental data
Journal Articles

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Paulina B. Lange, Bhavjot Bindra, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Brett Glotzbecker, MD, Jerome Ritz, MD, Bruce R Blazar, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, MD
Journal: Blood
Blood (2013) 122 (21): 3335.
https://doi.org/10.1182/blood.V122.21.3335.3335
Published: 2013